Dermacyd Infantile - Acceptability
- Conditions
- Healthy volunteers (hygiene)MedDRA version: 17.1Level: PTClassification code 10053339Term: Routine health maintenanceSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Not possible to specify
- Registration Number
- EUCTR2014-004666-14-Outside-EU/EEA
- Lead Sponsor
- Sanofi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- 31
Healthy female and male volunteers, aged between 0 and 12 years old; intact skin in the area where the test product will be applied (body); use of cosmetic products of the same category; willingness in following the study procedures; to be able to attend the study visits;
Are the trial subjects under 18? yes
Number of subjects for this age range: 31
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•Pregnancy or risk of pregnancy;
•Lactation
•Use of Anti-inflammatory, immunossupression or anti-histaminic
drugs;
•Atopic or allergic history to cosmetic products;
•Active cutaneous disease in the tested area;
•Disease that causes decrease of immunity, such as diabetes and HIV;
•Endocrine pathologies;
•Intense solar exposure 15 days before the evaluation;
•Any treatment in the four months before the selection;
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To prove the safety of the infantile formulation in normal and usual daily hygiene conditions.;Secondary Objective: Not applicable;Primary end point(s): - Number of subjects with skin reaction in the tested region.;Timepoint(s) of evaluation of this end point: 21 days
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable